Direct emissions
5,714
tCO2e
D
Dechra Pharmaceuticals Limited
Explore carbon emissions data for Dechra Pharmaceuticals Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Dechra Pharmaceuticals Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
138,912 tCO2e (Market Based)
Scope 1
tCO2e
5,714
Scope 2 (Market Based)
tCO2e
1,753
Scope 3 total
tCO2e
131,445
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
174,513
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
9,381
9,381
Upstream
+ upstream Scope 3
114,937
113,819
Total
+ all Scope 3
174,513
170,043
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Dechra Pharmaceuticals Limited reported 138,912 tCO₂e in 2025.
- Scope 3 accounted for 95% of emissions.
- Reported across 11 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the market based methodology.
According to available emissions disclosures, Dechra Pharmaceuticals Limited reported total yearly emissions of 138,912 tCO₂e in 2025. Scope 3 emissions accounted for 95% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 5.2, placing it mid-pack within its sector for sustainability performance, and received a transparency score of 97.0, an exceptional result, reflecting open disclosure across nearly every key emissions metric.
Total Emissions across all scopes
138,912 tCO2e (Market Based)
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
4,061
tCO2eMarket based
1,753
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
54,631
tCO2eCat 2
Capital goods
10,692
tCO2eCat 3
Fuel & energy related activities
2,537
tCO2eCat 4
Upstream transportation & distribution
9,513
tCO2eCat 5
Waste generated in operations
53
tCO2eCat 6
Business travel
3,372
tCO2eCat 7
Employee commuting
2,335
tCO2eCat 8
Upstream leased assets
890
tCO2eCat 9
Downstream transportation & distribution
2,723
tCO2eCat 10
Processing of sold products
890
tCO2eCat 11
Use of sold products
41,609
tCO2eCat 12
End-of-life treatment of sold products
419
tCO2eCat 13
Downstream leased assets
890
tCO2eCat 14
Franchises
890
tCO2eCat 15
Investments
3
tCO2e4 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Climate targets
Science Based Targets initiative
Near-term target
Targets set (1.5°C), target year 2030
Long-term target
Targets set, target year 2050
Net zero
Targets set, by 2050
Source: Science Based Targets initiative, Companies Taking Action.
Contact Info
Website
www.dechra.comAddress
24
Cheshire Avenue Cheshire Business Park
Lostock Gralam
Northwich
Cheshire
CW9 7UA
Country
United Kingdom
Phone
+44 1606 814730Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Dechra Pharmaceuticals Limited's score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
Dechra Pharmaceuticals Limited has disclosed the emissions categories that are material for its industry, so there's no single bucket dragging the transparency score down. The breakdown above shows full coverage across the categories that matter most for this kind of company.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
Dechra Pharmaceuticals Limited carbon emissions FAQs
What are Dechra Pharmaceuticals Limited's carbon emissions?
In its 2025 reporting year, Dechra Pharmaceuticals Limited disclosed total emissions of 138,912 tCO2e across all scopes. Scope 3 accounted for the largest share, around 95% of the total.
Does Dechra Pharmaceuticals Limited report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, Dechra Pharmaceuticals Limited's available disclosure covers Scope 1 (5,714 tCO2e), Scope 2 (1,753 tCO2e), Scope 3 across 11 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Dechra Pharmaceuticals Limited's emissions reporting?
Dechra Pharmaceuticals Limited has a Mycelium transparency score of 97 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is Dechra Pharmaceuticals Limited sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Dechra Pharmaceuticals Limited has a Mycelium Score of 5.2 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is Dechra Pharmaceuticals Limited environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Dechra Pharmaceuticals Limited disclosed 138,912 tCO2e for 2025, and its Mycelium Score of 5.2 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
